Zylox-Tonbridge Medical Technology Future Growth
Future criteria checks 2/6
Zylox-Tonbridge Medical Technology is forecast to grow earnings and revenue by 72.1% and 30.6% per annum respectively while EPS is expected to grow by 71.2% per annum.
Key information
72.1%
Earnings growth rate
71.2%
EPS growth rate
| Medical Equipment earnings growth | 14.2% |
| Revenue growth rate | 30.6% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 03 Feb 2023 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 1,045 | N/A | -49 | N/A | 1 |
| 12/31/2024 | 803 | N/A | -133 | N/A | 2 |
| 12/31/2023 | 533 | -42 | -315 | -59 | 2 |
| 12/31/2022 | 332 | -116 | -406 | -134 | 2 |
| 6/30/2022 | 259 | -155 | -247 | -122 | N/A |
| 3/31/2022 | 219 | -178 | -227 | -119 | N/A |
| 12/31/2021 | 178 | -200 | -206 | -116 | N/A |
| 9/30/2021 | 137 | -168 | -186 | -107 | N/A |
| 6/30/2021 | 97 | -135 | -166 | -98 | N/A |
| 3/31/2021 | 62 | -118 | -147 | -90 | N/A |
| 12/31/2020 | 28 | -100 | -127 | -82 | N/A |
| 12/31/2019 | 5 | -67 | -95 | -53 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 818 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 818 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 818 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 818's revenue (30.6% per year) is forecast to grow faster than the German market (4.6% per year).
High Growth Revenue: 818's revenue (30.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 818's Return on Equity is forecast to be high in 3 years time